133 related articles for article (PubMed ID: 32103002)
21. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
22. Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2.
Masson R; Nicklin SA; Craig MA; McBride M; Gilday K; Gregorevic P; Allen JM; Chamberlain JS; Smith G; Graham D; Dominiczak AF; Napoli C; Baker AH
Hypertension; 2009 Apr; 53(4):694-700. PubMed ID: 19221212
[TBL] [Abstract][Full Text] [Related]
23. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
Rentzsch B; Todiras M; Iliescu R; Popova E; Campos LA; Oliveira ML; Baltatu OC; Santos RA; Bader M
Hypertension; 2008 Nov; 52(5):967-73. PubMed ID: 18809792
[TBL] [Abstract][Full Text] [Related]
24. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
25. Benzoylaconitine: A promising ACE2-targeted agonist for enhancing cardiac function in heart failure.
Zhang QQ; Chen QS; Feng F; Cao X; Chen XF; Zhang H
Free Radic Biol Med; 2024 Mar; 214():206-218. PubMed ID: 38369076
[TBL] [Abstract][Full Text] [Related]
26. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat.
Rivière G; Michaud A; Breton C; VanCamp G; Laborie C; Enache M; Lesage J; Deloof S; Corvol P; Vieau D
Hypertension; 2005 Nov; 46(5):1169-74. PubMed ID: 16203874
[TBL] [Abstract][Full Text] [Related]
29. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.
Keidar S; Gamliel-Lazarovich A; Kaplan M; Pavlotzky E; Hamoud S; Hayek T; Karry R; Abassi Z
Circ Res; 2005 Oct; 97(9):946-53. PubMed ID: 16179584
[TBL] [Abstract][Full Text] [Related]
31. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
[TBL] [Abstract][Full Text] [Related]
32. FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice.
Pan X; Shao Y; Wu F; Wang Y; Xiong R; Zheng J; Tian H; Wang B; Wang Y; Zhang Y; Han Z; Qu A; Xu H; Lu A; Yang T; Li X; Xu A; Du J; Lin Z
Cell Metab; 2018 Jun; 27(6):1323-1337.e5. PubMed ID: 29706566
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats.
Zhang LC; Li ZZ; Yu YS; Wang ZB; Wei X; Su DF; Li L
Biol Pharm Bull; 2011; 34(9):1398-403. PubMed ID: 21881224
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells.
Warner FJ; Lew RA; Smith AI; Lambert DW; Hooper NM; Turner AJ
J Biol Chem; 2005 Nov; 280(47):39353-62. PubMed ID: 16166094
[TBL] [Abstract][Full Text] [Related]
35. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
36. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.
Huentelman MJ; Grobe JL; Vazquez J; Stewart JM; Mecca AP; Katovich MJ; Ferrario CM; Raizada MK
Exp Physiol; 2005 Sep; 90(5):783-90. PubMed ID: 16049057
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
He H; Liu L; Chen Q; Liu A; Cai S; Yang Y; Lu X; Qiu H
Cell Transplant; 2015; 24(9):1699-715. PubMed ID: 25291359
[TBL] [Abstract][Full Text] [Related]
38. Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
Ohkura SI; Usui S; Takashima SI; Takuwa N; Yoshioka K; Okamoto Y; Inagaki Y; Sugimoto N; Kitano T; Takamura M; Wada T; Kaneko S; Takuwa Y
PLoS One; 2017; 12(8):e0182329. PubMed ID: 28771545
[TBL] [Abstract][Full Text] [Related]
39. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.
Bae EH; Fang F; Williams VR; Konvalinka A; Zhou X; Patel VB; Song X; John R; Oudit GY; Pei Y; Scholey JW
Kidney Int; 2017 Jun; 91(6):1347-1361. PubMed ID: 28249676
[TBL] [Abstract][Full Text] [Related]
40. ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
Mak KY; Chin R; Cunningham SC; Habib MR; Torresi J; Sharland AF; Alexander IE; Angus PW; Herath CB
Mol Ther; 2015 Sep; 23(9):1434-43. PubMed ID: 25997428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
